Abstract
In this issue of Blood, Bhatt et al describe direct cytotoxic and indirect immune cell-mediated effects of interleukin-21 (IL-21) in mantle cell lymphoma (MCL), providing a preclinical rationale for IL-21 therapy in this aggressive disease.
MeSH terms
-
Animals
-
Female
-
Humans
-
Immunologic Factors / immunology*
-
Immunologic Factors / therapeutic use*
-
Interleukins / immunology*
-
Interleukins / therapeutic use*
-
Lymphoma, Mantle-Cell / immunology*
-
Lymphoma, Mantle-Cell / therapy*
Substances
-
Immunologic Factors
-
Interleukins